Skip to main content
Top

Drugs

Issue 4/2024

Content (12 Articles)

Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?

Sanne M. Buijs, Stijn L. W. Koolen, Ron H. J. Mathijssen, Agnes Jager

Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines

Congrui Zhu, Shengmei Pang, Jiaqi Liu, Qiangde Duan

Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials

Yifan Wang, He Yi, Weixia Sun, Hekai Yu, Wenxuan Tao, Xiaojin Yu, Dianrong Jia, Yingzhao Liu, Stephen J. Pandol, Ling Li

Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease

Amy Zhuang-Yan, Yahiya Y. Syed

Aponermin: First Approval

Sohita Dhillon

Eplontersen: First Approval

Tina Nie

Fidanacogene Elaparvovec: First Approval

Sohita Dhillon

Correction: Eplontersen: First Approval

  • Open Access
  • Correction

Tina Nie

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images